NGM Biopharmaceuticals Inc (NASDAQ:NGM)

13.74
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
10.49
Today|||52-Week Range
27.25
-22.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Operating ActivitiesNet Income / Starting Line-6.9M-14.2M-493.0K--
 
 
 
 
Depreciation3.5M6.4M7.2M--
 
 
 
 
Total Other Cash Flow7.2M8.0M7.1M--
 
 
 
 
Funds From Operations3.8M325.0K13.8M--
 
 
 
 
Funds From/For Other Operating Expenses2.5M17.7M23.6M--
 
 
 
 
Net Cash Flow - Operating Activities1.3M-17.4M-9.8M--
 
 
 
 
 
InvestingIncrease In Investments-132.6M-217.3M-133.6M--
 
 
 
 
Decrease In Investments92.7M220.9M178.2M--
 
 
 
 
Capital Expenditures-24.8M-6.4M-5.8M--
 
 
 
 
Net Cash Flow Investing-64.7M-2.8M38.7M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale231.0K339.0K2.6M--
 
 
 
 
Common Preferred Redeemed0.000.00-185.0K--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing231.0K339.0K2.4M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-63.2M-19.9M31.3M--